BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 28589370)

  • 1. Splicing factors differentially expressed in psoriasis alter mRNA maturation of disease-associated EDA+ fibronectin.
    Szlavicz E; Szabo K; Groma G; Bata-Csorgo Z; Pagani F; Kemeny L; Szell M
    Mol Cell Biochem; 2017 Dec; 436(1-2):189-199. PubMed ID: 28589370
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of psoriasis-relevant gene expression and exon usage alterations after silencing of SR-rich splicing regulators.
    Szlavicz E; Olah P; Szabo K; Pagani F; Bata-Csorgo Z; Kemeny L; Szell M
    Exp Dermatol; 2018 Jun; 27(6):656-662. PubMed ID: 29512856
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proliferating keratinocytes are putative sources of the psoriasis susceptibility-related EDA+ (extra domain A of fibronectin) oncofetal fibronectin.
    Széll M; Bata-Csörgo Z; Koreck A; Pivarcsi A; Polyánka H; Szeg C; Gaál M; Dobozy A; Kemény L
    J Invest Dermatol; 2004 Sep; 123(3):537-46. PubMed ID: 15304094
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Abnormal regulation of fibronectin production by fibroblasts in psoriasis.
    Gubán B; Vas K; Balog Z; Manczinger M; Bebes A; Groma G; Széll M; Kemény L; Bata-Csörgő Z
    Br J Dermatol; 2016 Mar; 174(3):533-41. PubMed ID: 26471375
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overexpression of the oncofetal Fn variant containing the EDA splice-in segment in the dermal-epidermal junction of psoriatic uninvolved skin.
    Ting KM; Rothaupt D; McCormick TS; Hammerberg C; Chen G; Gilliam AC; Stevens S; Culp L; Cooper KD
    J Invest Dermatol; 2000 Apr; 114(4):706-11. PubMed ID: 10733677
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Basal keratinocytes from uninvolved psoriatic skin exhibit accelerated spreading and focal adhesion kinase responsiveness to fibronectin.
    Chen G; McCormick TS; Hammerberg C; Ryder-Diggs S; Stevens SR; Cooper KD
    J Invest Dermatol; 2001 Dec; 117(6):1538-45. PubMed ID: 11886520
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The anti-apoptotic protein G1P3 is overexpressed in psoriasis and regulated by the non-coding RNA, PRINS.
    Szegedi K; Sonkoly E; Nagy N; Németh IB; Bata-Csörgo Z; Kemény L; Dobozy A; Széll M
    Exp Dermatol; 2010 Mar; 19(3):269-78. PubMed ID: 20377629
    [TBL] [Abstract][Full Text] [Related]  

  • 8. mRNA expression and protein distribution of fibronectin splice variants and high-molecular weight tenascin-C in different phases of human fracture healing.
    Kilian O; Dahse R; Alt V; Zardi L; Hentschel J; Schnettler R; Kosmehl H
    Calcif Tissue Int; 2008 Aug; 83(2):101-11. PubMed ID: 18663401
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of tenascin-C splice variants by human skin cells.
    Latijnhouwers MA; de Jongh GJ; Bergers M; de Rooij MJ; Schalkwijk J
    Arch Dermatol Res; 2000 Sep; 292(9):446-54. PubMed ID: 11000288
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of fibronectin expression and splicing in migrating epithelial cells: migrating MDCK cells produce a lesser amount of, but more active, fibronectin.
    Inoue T; Nabeshima K; Shimao Y; Meng JY; Koono M
    Biochem Biophys Res Commun; 2001 Feb; 280(5):1262-8. PubMed ID: 11162664
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The proteasome maturation protein POMP increases proteasome assembly and activity in psoriatic lesional skin.
    Zieba BA; Henry L; Lacroix M; Jemaà M; Lavabre-Bertrand T; Meunier L; Coux O; Stoebner PE
    J Dermatol Sci; 2017 Oct; 88(1):10-19. PubMed ID: 28728908
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro and in situ expression of IL-23 by keratinocytes in healthy skin and psoriasis lesions: enhanced expression in psoriatic skin.
    Piskin G; Sylva-Steenland RM; Bos JD; Teunissen MB
    J Immunol; 2006 Feb; 176(3):1908-15. PubMed ID: 16424222
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Localization of elevated transforming growth factor-alpha in psoriatic epidermis.
    Turbitt ML; Akhurst RJ; White SI; MacKie RM
    J Invest Dermatol; 1990 Aug; 95(2):229-32. PubMed ID: 2380581
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of heparin-binding EGF-like growth factor and amphiregulin in the epidermal proliferation of psoriasis in cooperation with TNFalpha.
    Yoshida A; Kanno H; Watabe D; Akasaka T; Sawai T
    Arch Dermatol Res; 2008 Jan; 300(1):37-45. PubMed ID: 17960400
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TGFβ1-mediated expression and alternative splicing of Fibronectin Extra Domain A in human podocyte culture.
    Madne TH; Dockrell MEC
    Cell Mol Biol (Noisy-le-grand); 2018 Feb; 64(3):17-24. PubMed ID: 29506626
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fibronectin and alpha5 integrin regulate keratinocyte cell cycling. A mechanism for increased fibronectin potentiation of T cell lymphokine-driven keratinocyte hyperproliferation in psoriasis.
    Bata-Csorgo Z; Cooper KD; Ting KM; Voorhees JJ; Hammerberg C
    J Clin Invest; 1998 Apr; 101(7):1509-18. PubMed ID: 9525994
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of EDA+ and EDB+ fibronectin splice variants in bone.
    Kilian O; Dahse R; Alt V; Zardi L; Rosenhahn J; Exner U; Battmann A; Schnettler R; Kosmehl H
    Bone; 2004 Dec; 35(6):1334-45. PubMed ID: 15589214
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Altered expression of keratinocyte growth factor and its receptor in psoriasis.
    Finch PW; Murphy F; Cardinale I; Krueger JG
    Am J Pathol; 1997 Dec; 151(6):1619-28. PubMed ID: 9403712
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cellular localization of interleukin-8 and its inducer, tumor necrosis factor-alpha in psoriasis.
    Nickoloff BJ; Karabin GD; Barker JN; Griffiths CE; Sarma V; Mitra RS; Elder JT; Kunkel SL; Dixit VM
    Am J Pathol; 1991 Jan; 138(1):129-40. PubMed ID: 1702929
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transforming growth factor-beta1 regulates fibronectin isoform expression and splicing factor SRp40 expression during ATDC5 chondrogenic maturation.
    Han F; Gilbert JR; Harrison G; Adams CS; Freeman T; Tao Z; Zaka R; Liang H; Williams C; Tuan RS; Norton PA; Hickok NJ
    Exp Cell Res; 2007 May; 313(8):1518-32. PubMed ID: 17391668
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.